- Home
- AEHL vs PPBT Comparison
AEHL vs PPBT Comparison
Compare AEHL & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHL
- PPBT
- Stock Information
- Founded
- AEHL 1993
- PPBT 2010
- Country
- AEHL China
- PPBT Israel
- Employees
- AEHL N/A
- PPBT N/A
- Industry
- AEHL Building Materials
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- AEHL Industrials
- PPBT Health Care
- Exchange
- AEHL Nasdaq
- PPBT Nasdaq
- Market Cap
- AEHL 7.8M
- PPBT 6.3M
- IPO Year
- AEHL 2007
- PPBT N/A
- Fundamental
- Price
- AEHL $2.20
- PPBT $2.62
- Analyst Decision
- AEHL
- PPBT Strong Buy
- Analyst Count
- AEHL 0
- PPBT 1
- Target Price
- AEHL N/A
- PPBT $33.00
- AVG Volume (30 Days)
- AEHL 197.6K
- PPBT 31.7K
- Earning Date
- AEHL 05-01-2025
- PPBT 05-21-2025
- Dividend Yield
- AEHL N/A
- PPBT N/A
- EPS Growth
- AEHL N/A
- PPBT N/A
- EPS
- AEHL N/A
- PPBT N/A
- Revenue
- AEHL $98,773,000.00
- PPBT N/A
- Revenue This Year
- AEHL N/A
- PPBT N/A
- Revenue Next Year
- AEHL N/A
- PPBT N/A
- P/E Ratio
- AEHL N/A
- PPBT N/A
- Revenue Growth
- AEHL 36.99
- PPBT N/A
- 52 Week Low
- AEHL $1.79
- PPBT $2.00
- 52 Week High
- AEHL $256.40
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- AEHL 43.59
- PPBT 56.64
- Support Level
- AEHL $1.79
- PPBT $2.46
- Resistance Level
- AEHL $2.41
- PPBT $2.80
- Average True Range (ATR)
- AEHL 0.27
- PPBT 0.20
- MACD
- AEHL 0.01
- PPBT 0.04
- Stochastic Oscillator
- AEHL 41.85
- PPBT 66.96
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.